BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26774359)

  • 1. [Cholesterol and atherosclerosis. Historical considerations and treatment].
    Zárate A; Manuel-Apolinar L; Basurto L; De la Chesnaye E; Saldívar I
    Arch Cardiol Mex; 2016; 86(2):163-9. PubMed ID: 26774359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercholesterolemia As a Risk Factor for Cardiovascular Disease: Current Controversial Therapeutic Management.
    Zárate A; Manuel-Apolinar L; Saucedo R; Hernández-Valencia M; Basurto L
    Arch Med Res; 2016 Oct; 47(7):491-495. PubMed ID: 28262189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nikolai N. Anichkov and his theory of atherosclerosis.
    Konstantinov IE; Mejevoi N; Anichkov NM
    Tex Heart Inst J; 2006; 33(4):417-23. PubMed ID: 17215962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery of the pathophysiological aspects of atherosclerosis--a review.
    Hanke H; Lenz C; Finking G
    Acta Chir Belg; 2001; 101(4):162-9. PubMed ID: 11680058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History of lipidology and lipoprotein apheresis.
    Julius U
    Atheroscler Suppl; 2017 Nov; 30():1-8. PubMed ID: 29096824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low and high density lipoprotein--cholesterol and coronary atherothrombosis.
    Kanjuh V; Ostojić M; Lalić N; Stokić E; Adić-Cemerlić N; Gojković-Bukarica L
    Med Pregl; 2009; 62 Suppl 3():7-14. PubMed ID: 19702110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCSK9 inhibitors in the current management of atherosclerosis.
    Whayne TF
    Arch Cardiol Mex; 2017; 87(1):43-48. PubMed ID: 28038950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basic mechanisms: absorption and excretion of cholesterol and other sterols].
    Cofan Pujol M
    Clin Investig Arterioscler; 2014; 26(1):41-7. PubMed ID: 24461630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new cholesterol controversy - a little bit of history repeating?
    Kivipelto M; Solomon A; Blennow K; Olsson AG; Winblad B
    Acta Neurol Scand Suppl; 2006; 185():1-2. PubMed ID: 16866903
    [No Abstract]   [Full Text] [Related]  

  • 11. [Historical development of the cholesterol-atherosclerosis concept].
    Epstein FH
    Ther Umsch; 1990 Jun; 47(6):435-42. PubMed ID: 2197752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atherosclerosis, an historical approach].
    Lippi D; D'Elios MM; Gensini G
    Med Secoli; 2007; 19(1):273-83. PubMed ID: 18447179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cholesterol controversy continues.
    Hoefner DM
    MLO Med Lab Obs; 2008 Apr; 40(4):24, 26, 28 passim. PubMed ID: 18488541
    [No Abstract]   [Full Text] [Related]  

  • 14. Homozygous familial hypercholesterolaemia: update on management.
    France M
    Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.
    Urban D; Pöss J; Böhm M; Laufs U
    J Am Coll Cardiol; 2013 Oct; 62(16):1401-8. PubMed ID: 23973703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.
    Kazi DS; Moran AE; Coxson PG; Penko J; Ollendorf DA; Pearson SD; Tice JA; Guzman D; Bibbins-Domingo K
    JAMA; 2016 Aug; 316(7):743-53. PubMed ID: 27533159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipid-lowering drugs and PCSK9].
    Millán Núñez-Cortés J; Mostaza Prieto JM
    Clin Investig Arterioscler; 2016 May; 28 Suppl 2():9-13. PubMed ID: 27888906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of PCSK9 in lipid metabolism and atherosclerosis.
    Lin XL; Xiao LL; Tang ZH; Jiang ZS; Liu MH
    Biomed Pharmacother; 2018 Aug; 104():36-44. PubMed ID: 29758414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.